Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1997 1
2000 1
2003 1
2004 3
2005 1
2007 1
2008 1
2009 1
2010 3
2012 1
2013 1
2014 1
2015 1
2016 3
2017 5
2018 11
2019 5
2020 4
2021 6
2022 6
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.
DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, Konopleva M, Döhner H, Letai A, Fenaux P, Koller E, Havelange V, Leber B, Esteve J, Wang J, Pejsa V, Hájek R, Porkka K, Illés Á, Lavie D, Lemoli RM, Yamamoto K, Yoon SS, Jang JH, Yeh SP, Turgut M, Hong WJ, Zhou Y, Potluri J, Pratz KW. DiNardo CD, et al. Among authors: pejsa v. N Engl J Med. 2020 Aug 13;383(7):617-629. doi: 10.1056/NEJMoa2012971. N Engl J Med. 2020. PMID: 32786187 Clinical Trial.
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
Mateos MV, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Chiu C, Wang J, Carson R, Crist W, Deraedt W, Nguyen H, Qi M, San-Miguel J; ALCYONE Trial Investigators. Mateos MV, et al. N Engl J Med. 2018 Feb 8;378(6):518-528. doi: 10.1056/NEJMoa1714678. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231133 Free article. Clinical Trial.
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia.
Pratz KW, Panayiotidis P, Recher C, Wei X, Jonas BA, Montesinos P, Ivanov V, Schuh AC, DiNardo CD, Novak J, Pejsa V, Stevens D, Yeh SP, Kim I, Turgut M, Fracchiolla N, Yamamoto K, Ofran Y, Wei AH, Bui CN, Benjamin K, Kamalakar R, Potluri J, Mendes W, Devine J, Fiedler W. Pratz KW, et al. Among authors: pejsa v. Blood Cancer J. 2022 Apr 20;12(4):71. doi: 10.1038/s41408-022-00668-8. Blood Cancer J. 2022. PMID: 35443742 Free PMC article.
Ruxolitinib treatment improves muscle mass in patients with myelofibrosis.
Lucijanic M, Galusic D, Soric E, Sedinic M, Cubela M, Huzjan Korunic R, Pejsa V, Kusec R. Lucijanic M, et al. Among authors: pejsa v. Ann Hematol. 2021 Apr;100(4):1105-1106. doi: 10.1007/s00277-020-04243-8. Epub 2020 Sep 1. Ann Hematol. 2021. PMID: 32870367 No abstract available.
Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkin's lymphoma patients.
Lucijanić M, Huzjan Korunić R, Ivić M, Fazlić Džankić A, Jonjić Ž, Mitrović Z, Prka Ž, Piršić M, Jakšić O, Gaćina P, Vlasac Glasnović J, Pejša V. Lucijanić M, et al. Among authors: pejsa v. Wien Klin Wochenschr. 2022 Jan;134(1-2):80-82. doi: 10.1007/s00508-021-01850-x. Epub 2021 Apr 9. Wien Klin Wochenschr. 2022. PMID: 33835267
50 results